Lidingö, Sweden

Hans Gronlund

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hans Gronlund: Innovator in HPV Immunotherapy

Introduction

Hans Gronlund is a notable inventor based in Lidingö, Sweden. He has made significant contributions to the field of immunotherapy, particularly in the development of methods for expanding HPV immunogen specific T-cells. His work aims to enhance the treatment and prevention of HPV-related cancers.

Latest Patents

Hans Gronlund holds a patent for a method titled "Method for the expansion of HPV immunogen specific T-cells." This invention outlines a process that includes several steps: providing a phagocytosable particle with a core and a tightly associated HPV immunogen, supplying antigen-presenting cells (APCs), and facilitating the activation of T-cells harvested from a subject. The method aims to create an expanded population of therapeutically useful T-cells for cancer treatment, particularly for HPV positive cancers. He has 1 patent to his name.

Career Highlights

Hans is associated with Neogap Therapeutics AB, a company focused on innovative therapeutic solutions. His work at Neogap Therapeutics has positioned him as a key player in the field of cancer immunotherapy.

Collaborations

Hans collaborates with Ola Winqvist, contributing to advancements in immunotherapy research and development.

Conclusion

Hans Gronlund's innovative work in expanding HPV immunogen specific T-cells represents a significant advancement in cancer treatment. His contributions continue to pave the way for new therapeutic strategies against HPV-related cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…